Christoph Lengauer
2015
In 2015, Christoph Lengauer earned a total compensation of $930.1K as Chief Scientific Officer at Blueprint Medicines, a 46% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $161,591 |
|---|---|
| Option Awards | $349,382 |
| Salary | $415,000 |
| Other | $4,150 |
| Total | $930,123 |
Lengauer received $415K in salary, accounting for 45% of the total pay in 2015.
Lengauer also received $161.6K in non-equity incentive plan, $349.4K in option awards and $4.2K in other compensation.
Rankings
In 2015, Christoph Lengauer's compensation ranked 8,299th out of 13,638 executives tracked by ExecPay. In other words, Lengauer earned more than 39.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,299 out of 13,638 | 39th |
Division Manufacturing | 3,162 out of 5,190 | 39th |
Major group Chemicals And Allied Products | 1,149 out of 1,854 | 38th |
Industry group Drugs | 928 out of 1,528 | 39th |
Industry Pharmaceutical Preparations | 727 out of 1,182 | 39th |
Source: SEC filing on April 28, 2016.
Lengauer's colleagues
We found three more compensation records of executives who worked with Christoph Lengauer at Blueprint Medicines in 2015.